Mindmed and liechti lab provide results from their psilocybin r&d collaboration

New york, sept. 23, 2021 /prnewswire/ -- mind medicine (mindmed) inc. (nasdaq: mnmd), (neo: mmed), (de: mmq) (the "company"), a leading biotech company developing psychedelic-inspired therapies, is pleased to announce that dr. matthias liechti presented data from several ongoing studies at the insight conference in berlin, germany.

MNMD Ratings Summary

MNMD Quant Ranking